DB19317ExperimentalGene Therapies
KT-A261 is an adeno-associated viral vector serotype 2 (AAV2) encoded to express adalimumab. It is being investigated for the treatment of noninfectious uveitis.
- Code names
- KT-A261
Which companies are running trials of KT-A261, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account